NMPA Approval

Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

Approval Number

国药准字S20227015

Registration Date

March 26, 2024

Previous Approval Numbers

国药准字S20140005

Drug Information

Generic Name

精蛋白锌重组赖脯胰岛素混合注射液(25R)

Dosage Form

注射剂

Strength

3ml:300单位(预填充注射笔)

Drug Type

生物制品

Registration Date

March 26, 2024

Company Address

北京市通州区漷县镇南凤西一路8号

Company Address

北京市通州区漷县镇南凤西一路8号

Empowering clinical research with data-driven insights and AI-powered tools.

精蛋白锌重组赖脯胰岛素混合注射液(25R) - NMPA 批准文号 | MedPath